v3.25.3
Share-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity

The following table summarizes the stock option activity during the nine months ended September 30, 2025:

 

 

Stock
Option
Shares

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term
(in Years)

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

Outstanding, December 31, 2024

 

 

4,950,016

 

 

$

10.82

 

 

 

7.99

 

 

$

1,818

 

Granted

 

 

3,385,624

 

 

 

1.85

 

 

 

 

 

 

 

Exercised

 

 

(24,936

)

 

 

1.06

 

 

 

 

 

 

 

Cancelled/Forfeited

 

 

(796,199

)

 

 

10.90

 

 

 

 

 

 

 

Outstanding as of September 30, 2025

 

 

7,514,505

 

 

$

6.80

 

 

 

8.28

 

 

$

539

 

Options exercisable as of September 30, 2025

 

 

3,247,074

 

 

$

12.09

 

 

 

7.10

 

 

$

55

 

Vested and expected to vest as of September 30, 2025

 

 

7,514,505

 

 

$

6.80

 

 

 

8.28

 

 

$

539

 

Schedule of Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity

Activity with respect to the Company’s restricted stock units during the nine months ended September 30, 2025 is as follows:

 

 

Shares

 

 

Weighted Average
Grant Date Fair
Value

 

Nonvested shares at December 31, 2024

 

 

256,490

 

 

$

1.92

 

Granted

 

 

2,567,272

 

 

 

1.68

 

Vested/Issued

 

 

(387,925

)

 

 

1.60

 

Forfeited

 

 

(38,456

)

 

 

1.92

 

Nonvested shares at September 30, 2025

 

 

2,397,381

 

 

$

1.71

 

Schedule of Recognized Compensation Cost Related to Employee and Non-employee Stock-Based Compensation Activity

The Company recognized the following compensation cost related to employee and non-employee share-based compensation activity for the periods presented (in thousands):

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Selling, general and administrative

 

$

1,777

 

 

$

1,590

 

 

$

4,917

 

 

$

5,704

 

Research and development

 

 

941

 

 

 

967

 

 

 

2,568

 

 

 

3,281

 

Total

 

$

2,718

 

 

$

2,557

 

 

$

7,485

 

 

$

8,985

 

Schedule of Stock Options Valuation Assumptions

The calculation was based on the following assumptions:

 

 

Three Months Ended September 30, (1)

 

 

Nine Months Ended September 30,

 

 

2025

 

 

2025

 

 

2024

 

Weighted average grant date fair value (per share)

 

$

1.86

 

 

$

1.85

 

 

$

1.39

 

Risk-free interest rate

 

3.94%

 

 

3.94% - 4.19%

 

 

4.13% - 4.29%

 

Expected volatility

 

84.69%

 

 

84.03% - 89.48%

 

 

89.22% - 91.46%

 

Expected term (in years)

 

6.08

 

 

5.49 - 6.08

 

 

5.00 - 6.08

 

Expected dividend yield

 

 

 

 

 

 

 

 

 

(1) No awards were granted during the three months ended September 30, 2024